Clinical Trial

Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study

Study acronym: SYMON III
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-03
notable Trial sites expanded: 0 -> 5 locations 2026-07-03
Trial Details
NCT Number NCT07425587
Lead Sponsor Bluejay Diagnostics, Inc.
Conditions Sepsis, Septic Shock
Enrollment 450 participants
Start Date 2026-05-04
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-02